{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:55:40Z","timestamp":1790664940508,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s13555-026-01728-8","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T07:07:30Z","timestamp":1775891250000},"page":"2297-2342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review"],"prefix":"10.1007","volume":"16","author":[{"given":"Kevin","family":"D\u00edez-Madue\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Arg\u00fcello-Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4551-6353","authenticated-orcid":false,"given":"Diego","family":"Buend\u00eda-Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Mart\u00edn-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saceda-Corralo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"6","key":"1728_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.17161\/kjm.vol17.22560","volume":"17","author":"S Jaroonwanichkul","year":"2024","unstructured":"Jaroonwanichkul S, Rajpara A. Dissecting cellulitis of the scalp. Kans J Med. 2024;17(6):160. https:\/\/doi.org\/10.17161\/kjm.vol17.22560.","journal-title":"Kans J Med"},{"issue":"5","key":"1728_CR2","doi-asserted-by":"publisher","DOI":"10.5070\/D3205022692","volume":"20","author":"N Scheinfeld","year":"2014","unstructured":"Scheinfeld N. Dissecting cellulitis (perifolliculitis capitis abscedens et suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa. Dermatol Online J. 2014;20(5):22692.","journal-title":"Dermatol Online J"},{"issue":"1","key":"1728_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/ddg.15271","volume":"22","author":"FJ Melgosa Ramos","year":"2024","unstructured":"Melgosa Ramos FJ, Berna-Rico E, Suarez-Valle A, et al. Determinant factors of biological therapy for dissecting cellulitis of the scalp. J Dtsch Dermatol Ges. 2024;22(1):115\u20137. https:\/\/doi.org\/10.1111\/ddg.15271.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"1728_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.abd.2024.06.003","volume":"100","author":"P Gerlero","year":"2025","unstructured":"Gerlero P, Peron I, Doche I, Freitas Rodrigues E, Macedo T, Rivitti-Machado MC. Dissecting cellulitis of the scalp: clinical characteristics and impact on quality of life of 66 Brazilian patients. An Bras Dermatol. 2025;100(1):155\u20138. https:\/\/doi.org\/10.1016\/j.abd.2024.06.003.","journal-title":"An Bras Dermatol"},{"issue":"8","key":"1728_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000003015","volume":"8","author":"TA Cuellar","year":"2020","unstructured":"Cuellar TA, Roh DS, Sampson CE. Dissecting cellulitis of the scalp: a review and case studies of surgical reconstruction. Plast Reconstr Surg Glob Open. 2020;8(8):e3015. https:\/\/doi.org\/10.1097\/GOX.0000000000003015.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"5","key":"1728_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.abd.2019.09.006","volume":"94","author":"DF Melo","year":"2019","unstructured":"Melo DF, Slaibi EB, Siqueira TMFM, Tortelly VD. Trichoscopy findings in dissecting cellulitis. An Bras Dermatol. 2019;94(5):608\u201311. https:\/\/doi.org\/10.1016\/j.abd.2019.09.006.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"1728_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.clindermatol.2021.01.002","volume":"39","author":"A Federico","year":"2021","unstructured":"Federico A, Rossi A, Caro G, et al. Are dissecting cellulitis and hidradenitis suppurativa different diseases? Clin Dermatol. 2021;39(3):496\u20139. https:\/\/doi.org\/10.1016\/j.clindermatol.2021.01.002.","journal-title":"Clin Dermatol"},{"issue":"4","key":"1728_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ad.2014.06.016","volume":"106","author":"C Bern\u00e1rdez","year":"2015","unstructured":"Bern\u00e1rdez C, Molina-Ruiz AM, Requena L. Histopatolog\u00eda de las alopecias. Parte II: alopecias cicatriciales. Actas Dermosifiliogr. 2015;106(4):260\u201370. https:\/\/doi.org\/10.1016\/j.ad.2014.06.016.","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"1728_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/bjd.13999","volume":"174","author":"A Badaoui","year":"2016","unstructured":"Badaoui A, Reygagne P, Cavelier-Balloy B, et al. Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of literature. Br J Dermatol. 2016;174(2):421\u20133. https:\/\/doi.org\/10.1111\/bjd.13999.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1728_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/archdermatol.2010.16","volume":"146","author":"AA Navarini","year":"2010","unstructured":"Navarini AA, Tr\u00fceb RM. 3 cases of dissecting cellulitis of the scalp treated with adalimumab: control of inflammation within residual structural disease. Arch Dermatol. 2010;146(5):517\u201320. https:\/\/doi.org\/10.1001\/archdermatol.2010.16.","journal-title":"Arch Dermatol"},{"key":"1728_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03720-5","volume":"20","author":"N Heidari","year":"2025","unstructured":"Heidari N, Ghannadzadeh Kermani Pour R, Farshbafnadi M, Heidari A, Ghane Y. A systematic review of tumor necrosis factor-\u03b1 blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment. Orphanet J Rare Dis. 2025;20:236. https:\/\/doi.org\/10.1186\/s13023-025-03720-5.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"1728_CR12","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1007\/s13555-023-01018-7","volume":"13","author":"R Masson","year":"2023","unstructured":"Masson R, Jeong CY, Ma E, et al. Treatments for dissecting cellulitis of the scalp: a systematic review and treatment algorithm. Dermatol Ther (Heidelb). 2023;13(11):2487\u2013526. https:\/\/doi.org\/10.1007\/s13555-023-01018-7.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"9","key":"1728_CR13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","volume":"74","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. Declaraci\u00f3n PRISMA 2020: una gu\u00eda actualizada para la publicaci\u00f3n de revisiones sistem\u00e1ticas. Rev Esp Cardiol. 2021;74(9):790\u20139. https:\/\/doi.org\/10.1016\/j.recesp.2021.06.016.","journal-title":"Rev Esp Cardiol"},{"key":"1728_CR14","unstructured":"JBI Critical Appraisal Tools. JBI. https:\/\/jbi.global\/critical-appraisal-tools. Accessed 10 Nov 2025."},{"issue":"4","key":"1728_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jaad.2025.06.005","volume":"93","author":"R Ghanshani","year":"2025","unstructured":"Ghanshani R, Chung CS, Park SE, et al. Dissecting cellulitis of the scalp: treatment responses in a retrospective cohort study. J Am Acad Dermatol. 2025;93(4):1101\u20133. https:\/\/doi.org\/10.1016\/j.jaad.2025.06.005.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"1728_CR16","doi-asserted-by":"publisher","DOI":"10.12890\/2025_005743","volume":"12","author":"A Al-Mamoori","year":"2025","unstructured":"Al-Mamoori A, Al-Badri SG, Sayed SBH, Al-Daraji W. Janus kinase inhibitors as a breakthrough treatment for refractory dissecting cellulitis of the scalp. Eur J Case Rep Intern Med. 2025;12(9):005743. https:\/\/doi.org\/10.12890\/2025_005743.","journal-title":"Eur J Case Rep Intern Med"},{"key":"1728_CR17","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.2147\/JIR.S504393","volume":"18","author":"M Qiu","year":"2025","unstructured":"Qiu M, Man X, Jing J. Dissecting cellulitis of the scalp successfully treated with a combination of ixekizumab and tofacitinib. JIR. 2025;18:6959\u201361. https:\/\/doi.org\/10.2147\/JIR.S504393.","journal-title":"JIR"},{"issue":"3","key":"1728_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000537914","volume":"10","author":"N Schettini","year":"2024","unstructured":"Schettini N, Marzola E, Pacetti L, Cavaliere S, Bettoli V. A case of dissecting cellulitis of the scalp, hidradenitis suppurativa, and conglobate acne successfully treated with secukinumab. Skin Appendage Disord. 2024;10(3):232\u20135. https:\/\/doi.org\/10.1159\/000537914.","journal-title":"Skin Appendage Disord"},{"issue":"1","key":"1728_CR19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52377","volume":"16","author":"Z Islam","year":"2024","unstructured":"Islam Z, Toker M, Gandhi IM, Sher A, Campton K. Improvement of recalcitrant dissecting cellulitis of the scalp after a trial of upadacitinib. Cureus. 2024;16(1):e52377. https:\/\/doi.org\/10.7759\/cureus.52377.","journal-title":"Cureus"},{"issue":"10","key":"1728_CR20","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1111\/1346-8138.17232","volume":"51","author":"S Jin","year":"2024","unstructured":"Jin S, Yue C, Wang S, Wang P. Oral abrocitinib in the treatment of refractory dissecting cellulitis of the scalp: a case report. J Dermatol. 2024;51(10):e329\u201330. https:\/\/doi.org\/10.1111\/1346-8138.17232.","journal-title":"J Dermatol"},{"key":"1728_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jdcr.2023.10.011","volume":"42","author":"KN Nagshabandi","year":"2023","unstructured":"Nagshabandi KN, Alsalhi A, Alahmadi D, Almesfer S, Alajlan AM. Refractory dissecting cellulitis of the scalp treated with risankizumab: 2 case reports. JAAD Case Rep. 2023;42:87\u201390. https:\/\/doi.org\/10.1016\/j.jdcr.2023.10.011.","journal-title":"JAAD Case Rep"},{"issue":"3","key":"1728_CR22","doi-asserted-by":"publisher","first-page":"9699","DOI":"10.4081\/dr.2023.9699","volume":"15","author":"S Miura","year":"2023","unstructured":"Miura S, Tsunoda K, Amano H. A case of perifolliculitis capitis abscedens et suffodiens and acne conglobata effectively treated with a tumor necrosis factor \u03b1 inhibitor. Dermatol Reports. 2023;15(3):9699. https:\/\/doi.org\/10.4081\/dr.2023.9699.","journal-title":"Dermatol Reports"},{"key":"1728_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdcr.2023.06.041","volume":"39","author":"N Almuhanna","year":"2023","unstructured":"Almuhanna N, Alhamazani R, Alkhezzi S, et al. Successful treatment of dissecting cellulitis with certolizumab pegol in a pregnant patient. JAAD Case Rep. 2023;39:1\u20132. https:\/\/doi.org\/10.1016\/j.jdcr.2023.06.041.","journal-title":"JAAD Case Rep"},{"issue":"5","key":"1728_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/ced\/llad036","volume":"48","author":"M Alzahrani","year":"2023","unstructured":"Alzahrani M, Coste V, Konstantinou MP, et al. Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: a retrospective multicentre study. Clin Exp Dermatol. 2023;48(5):528\u201330. https:\/\/doi.org\/10.1093\/ced\/llad036.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"1728_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.17816\/dv133626","volume":"26","author":"NP Teplyuk","year":"2023","unstructured":"Teplyuk NP, Konchina SA, Pirogova AS. The experience of follicular occlusion syndrome treatment with tumor necrosis factor inhibitors. Russ J Skin Vener Dis. 2023;26(2):157\u201370. https:\/\/doi.org\/10.17816\/dv133626.","journal-title":"Russ J Skin Vener Dis"},{"key":"1728_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1132574","volume":"10","author":"Y Yu","year":"2023","unstructured":"Yu Y, Ding X, Guo F, Ze K, Sun X, Li X. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: a case report and literature review. Front Med (Lausanne). 2023;10:1132574. https:\/\/doi.org\/10.3389\/fmed.2023.1132574.","journal-title":"Front Med (Lausanne)"},{"key":"1728_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jdcr.2023.06.033","volume":"39","author":"JW Bernard","year":"2023","unstructured":"Bernard JW, Reddy S, Flowers RH. The successful use of oral apremilast for a case of dissecting cellulitis. JAAD Case Rep. 2023;39:122\u20134. https:\/\/doi.org\/10.1016\/j.jdcr.2023.06.033.","journal-title":"JAAD Case Rep"},{"key":"1728_CR28","doi-asserted-by":"publisher","unstructured":"Koike Y, Hattori N, Murota H. Serum cytokine\/chemokine levels in a patient with perifolliculitis capitis abscedens et suffodiens (dissecting cellulitis) successfully treated with the tumour necrosis factor \u03b1 inhibitor adalimumab. JEADV Clinical Practice. 2022;1(3):271\u20134. https:\/\/doi.org\/10.1002\/jvc2.51.","DOI":"10.1002\/jvc2.51"},{"issue":"8","key":"1728_CR29","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/ced.14789","volume":"46","author":"S Minakawa","year":"2021","unstructured":"Minakawa S, Matsuzaki Y, Rokunohe D, et al. Hidradenitis suppurativa with perifolliculitis capitis abscedens et suffodiens successfully treated with a human anti-tumour necrosis factor monoclonal antibody. Clin Exp Dermatol. 2021;46(8):1586\u20138. https:\/\/doi.org\/10.1111\/ced.14789.","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"1728_CR30","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1111\/1346-8138.15945","volume":"48","author":"I Kurokawa","year":"2021","unstructured":"Kurokawa I. Perifolliculitis capitis abscedens et suffodiens with hidradenitis suppurativa and nodulocystic acne treated with adalimumab. J Dermatol. 2021;48(8):e374\u20135. https:\/\/doi.org\/10.1111\/1346-8138.15945.","journal-title":"J Dermatol"},{"issue":"7","key":"1728_CR31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.36849\/JDD.5615","volume":"20","author":"V De Bedout","year":"2021","unstructured":"De Bedout V, Harper H, Miteva M, Lev-Tov H. Treatment dissecting cellulitis of the scalp with secukinumab. J Drugs Dermatol. 2021;20(7):776\u20137. https:\/\/doi.org\/10.36849\/JDD.5615.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"1728_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14829","volume":"34","author":"M Sanchez-Diaz","year":"2021","unstructured":"Sanchez-Diaz M, Martinez-Lopez A, Salvador-Rodriguez L, Montero-Vilchez T, Arias-Santiago S, Molina-Leyva A. The role of biologic treatment in special scenarios in hidradenitis suppurativa: facial and nape phenotype, dissecting cellulitis of the scalp, and lymphedema. Dermatol Ther. 2021;34(2):e14829. https:\/\/doi.org\/10.1111\/dth.14829.","journal-title":"Dermatol Ther"},{"issue":"1","key":"1728_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1684\/ejd.2021.3969","volume":"31","author":"L Frechet","year":"2021","unstructured":"Frechet L, Puzenat E, Charollais R, et al. Dissecting cellulitis of the scalp treated by tumour necrosis factor inhibitors: a case series. Eur J Dermatol. 2021;31(1):81\u20135. https:\/\/doi.org\/10.1684\/ejd.2021.3969.","journal-title":"Eur J Dermatol"},{"key":"1728_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/CCID.S301451","volume":"14","author":"A Alsantali","year":"2021","unstructured":"Alsantali A, Almalki B, Alharbi A. Recalcitrant dissecting cellulitis of the scalp treated successfully with adalimumab with hair regrowth: a case report. Clin Cosmet Investig Dermatol. 2021;14:455\u20138. https:\/\/doi.org\/10.2147\/CCID.S301451.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"7-8","key":"1728_CR35","doi-asserted-by":"publisher","first-page":"e1309","DOI":"10.1093\/milmed\/usz394","volume":"185","author":"E Maxon","year":"2020","unstructured":"Maxon E, Modlin K, Durso TA, Miletta NR. A case report of tumor necrosis factor alpha inhibitors in an active duty service member with dissecting cellulitis of the scalp resistant to treatment. Mil Med. 2020;185(7\u20138):e1309\u201311. https:\/\/doi.org\/10.1093\/milmed\/usz394.","journal-title":"Mil Med"},{"issue":"1","key":"1728_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/jdds.jdds_50_19","volume":"24","author":"S Muzumdar","year":"2020","unstructured":"Muzumdar S, Parikh S, Strober B. Treatment of refractory dissecting cellulitis of the scalp with guselkumab: case report. J Dermatol Dermatol Surg. 2020;24(1):52. https:\/\/doi.org\/10.4103\/jdds.jdds_50_19.","journal-title":"J Dermatol Dermatol Surg"},{"issue":"9","key":"1728_CR37","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/1346-8138.14998","volume":"46","author":"T Takahashi","year":"2019","unstructured":"Takahashi T, Yamasaki K, Terui H, et al. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: a case report and review of published cases. J Dermatol. 2019;46(9):802\u20137. https:\/\/doi.org\/10.1111\/1346-8138.14998.","journal-title":"J Dermatol"},{"issue":"3","key":"1728_CR38","first-page":"255","volume":"26","author":"I Sjerobabski Masnec","year":"2018","unstructured":"Sjerobabski Masnec I, Franceschi N. Perifolliculitis capitis abscedens et suffodiens treated with anti-tumor necrosis factor-alpha\u2014possible new treatment option. Acta Dermatovenerol Croat. 2018;26(3):255\u201389.","journal-title":"Acta Dermatovenerol Croat"},{"key":"1728_CR39","doi-asserted-by":"publisher","DOI":"10.14309\/crj.2018.8","volume":"5","author":"TA Syed","year":"2018","unstructured":"Syed TA, Ul Abideen Asad Z, Salem G, Garg K, Rubin E, Agudelo N. Dissecting cellulitis of the scalp: a rare dermatological manifestation of Crohn\u2019s disease. ACG Case Rep J. 2018;5:e8. https:\/\/doi.org\/10.14309\/crj.2018.8.","journal-title":"ACG Case Rep J"},{"issue":"4","key":"1728_CR40","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/bjd.14269","volume":"174","author":"Y Mansouri","year":"2016","unstructured":"Mansouri Y, Martin-Clavijo A, Newsome P, Kaur MR. Dissecting cellulitis of the scalp treated with tumour necrosis factor-\u03b1 inhibitors: experience with two agents. Br J Dermatol. 2016;174(4):916\u20138. https:\/\/doi.org\/10.1111\/bjd.14269.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1728_CR41","first-page":"102","volume":"34","author":"RF Martin-Garc\u00eda","year":"2015","unstructured":"Martin-Garc\u00eda RF, Rull\u00e1n JM. Refractory dissecting cellulitis of the scalp successfully controlled with adalimumab. P R Health Sci J. 2015;34(2):102\u20134.","journal-title":"P R Health Sci J"},{"issue":"3","key":"1728_CR42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/dth.12222","volume":"28","author":"FL Sand","year":"2015","unstructured":"Sand FL, Thomsen SF. Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients. Dermatol Ther. 2015;28(3):158\u201365. https:\/\/doi.org\/10.1111\/dth.12222.","journal-title":"Dermatol Ther"},{"issue":"10","key":"1728_CR43","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.piel.2015.04.017","volume":"30","author":"J Granizo-Rubio","year":"2015","unstructured":"Granizo-Rubio J, Pinos-Le\u00f3n V, Nu\u00f1ez M, Cabezas G. Celulitis disecante del cuero cabelludo: respuesta transitoria al tratamiento con infliximab. Piel. 2015;30(10):627\u20139. https:\/\/doi.org\/10.1016\/j.piel.2015.04.017.","journal-title":"Piel"},{"key":"1728_CR44","unstructured":"Pratsou\nP, Muc R, Kaur MR. Septal eosinophilic panniculitis associated with adalimumab therapy for dissecting cellulitis of the scalp. ResearchGate. https:\/\/www.researchgate.net\/publication\/289628037_Septal_eosinophilic_panniculitis_associated_with_adalimumab_therapy_for_dissecting_cellulitis_of_the_scalp. Accessed 3 Nov 2025."},{"issue":"8","key":"1728_CR45","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s11926-013-0346-y","volume":"15","author":"DT Lim","year":"2013","unstructured":"Lim DT, James NM, Hassan S, Khan MA. Spondyloarthritis associated with acne conglobata, hidradenitis suppurativa and dissecting cellulitis of the scalp: a review with illustrative cases. Curr Rheumatol Rep. 2013;15(8):346. https:\/\/doi.org\/10.1007\/s11926-013-0346-y.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"1728_CR46","first-page":"36","volume":"5","author":"U Wollina","year":"2012","unstructured":"Wollina U, Gemmeke A, Koch A. Dissecting cellulitis of the scalp responding to intravenous tumor necrosis factor-alpha antagonist. J Clin Aesthet Dermatol. 2012;5(4):36\u20139.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"8\u20139","key":"1728_CR47","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.annder.2010.06.001","volume":"137","author":"ME Deschamps","year":"2010","unstructured":"Deschamps ME, Payet S, Tournadre A, Soubrier M, Souteyrand P, D\u2019Incan M. Efficacit\u00e9 de l\u2019infliximab dans le traitement d\u2019une triade d\u2019occlusion folliculaire. Ann Dermatol Venereol. 2010;137(8\u20139):546\u201350. https:\/\/doi.org\/10.1016\/j.annder.2010.06.001.","journal-title":"Ann Dermatol Venereol"},{"issue":"10","key":"1728_CR48","first-page":"981","volume":"7","author":"SV Sukhatme","year":"2008","unstructured":"Sukhatme SV, Lenzy YM, Gottlieb AB. Refractory dissecting cellulitis of the scalp treated with adalimumab. J Drugs Dermatol. 2008;7(10):981\u20133.","journal-title":"J Drugs Dermatol"},{"key":"1728_CR49","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.clim.2010.03.253","volume":"135","author":"M Hession","year":"2010","unstructured":"Hession M, Lenzy Y, LaRaia A, Wasserman D, Layton C, Gottlieb A. Efficacy of adalimumab for the treatment of dissecting cellulitis of the scalp and disseminated granuloma annulare. Clin Immunol. 2010;135:S84. https:\/\/doi.org\/10.1016\/j.clim.2010.03.253.","journal-title":"Clin Immunol"},{"issue":"2","key":"1728_CR50","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2133.2008.08674.x","volume":"159","author":"HRC Brandt","year":"2008","unstructured":"Brandt HRC, Malheiros APR, Teixeira MG, Machado MCR. Perifolliculitis capitis abscedens et suffodiens successfully controlled with infliximab. Br J Dermatol. 2008;159(2):506\u20137. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08674.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1728_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.36849\/JDD.6699","volume":"21","author":"F Babalola","year":"2022","unstructured":"Babalola F, Chima M, Jobarteh R, Gottlieb A. Refractory dissecting cellulitis of the scalp treated with risankizumab. J Drugs Dermatol. 2022;21(3):313\u20134. https:\/\/doi.org\/10.36849\/JDD.6699.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"1728_CR52","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1308\/rcsann.2020.7096","volume":"103","author":"J Spiers","year":"2021","unstructured":"Spiers J, Vinnicombe Z, Singh G, Pouncey A, McEvoy H. Severe dissecting scalp cellulitis successfully treated with serial excisions in combination with anti-TNF therapy. Ann R Coll Surg Engl. 2021;103(6):e199\u2013201. https:\/\/doi.org\/10.1308\/rcsann.2020.7096.","journal-title":"Ann R Coll Surg Engl"},{"key":"1728_CR53","unstructured":"Cautela JM, Deboli T, Licciardello M, Dapavo P, Broganelli P, Fierro M. Dissecting cellulitis of the scalp in patients with hidradenitis suppurativa respondinig to adalimumab therapy. J Dermatol Nurses Assoc.\n2020;12(2):e0293433."},{"issue":"10","key":"1728_CR54","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/ecco-jcc\/jjaa078","volume":"14","author":"FM Phillips","year":"2020","unstructured":"Phillips FM, Verstockt B, Sebastian S, et al. Inflammatory cutaneous lesions in inflammatory bowel disease treated with vedolizumab or ustekinumab: an ECCO CONFER multicentre case series. J Crohns Colitis. 2020;14(10):1488\u201393. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa078.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"1728_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15626","volume":"35","author":"M Gamissans","year":"2022","unstructured":"Gamissans M, Roman\u00ed J, L\u00f3pez-Llunell C, Riera-Mart\u00ed N, Sin M. Dissecting cellulitis of the scalp: a review on clinical characteristics and management options in a series of 14 patients. Dermatol Ther. 2022;35(8):e15626. https:\/\/doi.org\/10.1111\/dth.15626.","journal-title":"Dermatol Ther"},{"issue":"3","key":"1728_CR56","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/ajd.13860","volume":"63","author":"A Awad","year":"2022","unstructured":"Awad A, Sinclair R. Treatment of dissecting cellulitis of the scalp with tildrakizumab. Aust J Dermatol. 2022;63(3):404\u20136. https:\/\/doi.org\/10.1111\/ajd.13860.","journal-title":"Aust J Dermatol"},{"issue":"1","key":"1728_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40268-020-00335-y","volume":"21","author":"W Guo","year":"2021","unstructured":"Guo W, Zhu C, Stevens G, Silverstein D. Analyzing the efficacy of Isotretinoin in treating dissecting cellulitis: a literature review and meta-analysis. Drugs R D. 2021;21(1):29\u201337. https:\/\/doi.org\/10.1007\/s40268-020-00335-y.","journal-title":"Drugs R D"},{"issue":"10443","key":"1728_CR58","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","volume":"403","author":"AB Kimball","year":"2024","unstructured":"Kimball AB, Jemec GBE, Sayed CJ, et al. Efficacy and safety of Q in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase\u00a03 trials. Lancet. 2024;403(10443):2504\u201319. https:\/\/doi.org\/10.1016\/S0140-6736(24)00101-6.","journal-title":"Lancet"},{"key":"1728_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-025-01569-x","author":"FJ Melgosa Ramos","year":"2025","unstructured":"Melgosa Ramos FJ, Mart\u00ednez Ruiz E, Galarreta Pascual M, Sanz-Motilva V, Martorell A. Secukinumab plus upadacitinib for the treatment of severe hidradenitis suppurativa and associated immune-mediated comorbidities: a case series. Dermatol Ther (Heidelb). 2025. https:\/\/doi.org\/10.1007\/s13555-025-01569-x.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1728_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jdcr.2024.12.008","volume":"56","author":"Z Islam","year":"2025","unstructured":"Islam Z, Choi S, Wang L, Andriano TM, Campton K. Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa. JAAD Case Rep. 2025;56:74\u20136. https:\/\/doi.org\/10.1016\/j.jdcr.2024.12.008.","journal-title":"JAAD Case Rep"},{"issue":"1","key":"1728_CR61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/bjd.18983","volume":"184","author":"AV Marzano","year":"2021","unstructured":"Marzano AV, Genovese G, Casazza G, et al. Evidence for a \u201cwindow of opportunity\u201d in hidradenitis suppurativa treated with Adalimumab: a retrospective, real-life multicentre cohort study. Br J Dermatol. 2021;184(1):133\u201340. https:\/\/doi.org\/10.1111\/bjd.18983.","journal-title":"Br J Dermatol"},{"issue":"5","key":"1728_CR62","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/bjd.21776","volume":"187","author":"N Yang","year":"2022","unstructured":"Yang N, Chen L, Shao J, Jiang F, Liu J, Li Z. Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to Dupilumab. Br J Dermatol. 2022;187(5):828\u201330.","journal-title":"Br J Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01728-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01728-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01728-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:18:28Z","timestamp":1779949108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01728-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1728"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01728-8","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors Kevin D\u00edez-Madue\u00f1o, Bel\u00e9n Arg\u00fcello-Marcos, Diego Buend\u00eda-Casta\u00f1o and Mar\u00eda \u00c1ngeles Mart\u00edn-D\u00edaz report no conflicts of interest relevant to this manuscript. David Saceda-Corralo is an Editorial Board member of\n                      Dermatology and Therapy\n                      . David Saceda-Corralo was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. He has no other conflicts of interest relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}